[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1232121A1 - 作為抗氧化治療的富勒烯化合物 - Google Patents

作為抗氧化治療的富勒烯化合物

Info

Publication number
HK1232121A1
HK1232121A1 HK17105228.4A HK17105228A HK1232121A1 HK 1232121 A1 HK1232121 A1 HK 1232121A1 HK 17105228 A HK17105228 A HK 17105228A HK 1232121 A1 HK1232121 A1 HK 1232121A1
Authority
HK
Hong Kong
Prior art keywords
antioxidant therapy
fullerene compounds
fullerene
compounds
antioxidant
Prior art date
Application number
HK17105228.4A
Other languages
English (en)
Inventor
Kiminobu Sugaya
Alexander Torres
Original Assignee
Univ Of Central Florida Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Central Florida Research Foundation filed Critical Univ Of Central Florida Research Foundation
Publication of HK1232121A1 publication Critical patent/HK1232121A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HK17105228.4A 2014-01-13 2017-05-23 作為抗氧化治療的富勒烯化合物 HK1232121A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461926883P 2014-01-13 2014-01-13
PCT/US2015/011268 WO2015106289A1 (en) 2014-01-13 2015-01-13 Fullerene compounds as antioxidant therapy

Publications (1)

Publication Number Publication Date
HK1232121A1 true HK1232121A1 (zh) 2018-01-05

Family

ID=53524429

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105228.4A HK1232121A1 (zh) 2014-01-13 2017-05-23 作為抗氧化治療的富勒烯化合物

Country Status (5)

Country Link
US (1) US20160331698A1 (zh)
EP (1) EP3094316A4 (zh)
JP (1) JP2017510546A (zh)
HK (1) HK1232121A1 (zh)
WO (1) WO2015106289A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10925867B2 (en) * 2015-06-29 2021-02-23 Bristol-Myers Squibb Company Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer
WO2020068817A1 (en) * 2018-09-24 2020-04-02 The Cleveland Clinic Foundation Fullerenes to treat diseases and conditions
KR102037721B1 (ko) * 2019-02-11 2019-10-29 주식회사 네프랩 풀러린 수를 포함하는 화장료 조성물 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698002B1 (fr) * 1992-11-13 1995-01-13 Oreal Composition cosmétique de maquillage contenant un fullerène ou un mélange de fullerènes comme agent pigmentant.
US5648523A (en) * 1995-10-26 1997-07-15 Chiang Long Y Fullerene derivatives as free-radical scavengers
US6303016B1 (en) * 1998-04-14 2001-10-16 Tda Research, Inc. Isolation of small-bandgap fullerenes and endohedral metallofullerenes
KR100972777B1 (ko) * 2003-01-27 2010-08-03 비타민 씨60 바이오리서치 가부시키가이샤 항산화 조성물과 외용 조성물
JP2006160664A (ja) * 2004-12-07 2006-06-22 Vitamin C60 Bioresearch Kk フリーラジカル疾患予防治療用組成物
US9084989B2 (en) * 2008-06-24 2015-07-21 University Of Florida Research Foundation, Inc. Enhancement of electron scavenging by water-soluble fullerenes

Also Published As

Publication number Publication date
WO2015106289A1 (en) 2015-07-16
EP3094316A1 (en) 2016-11-23
US20160331698A1 (en) 2016-11-17
EP3094316A4 (en) 2017-07-05
JP2017510546A (ja) 2017-04-13

Similar Documents

Publication Publication Date Title
PL3134402T3 (pl) Związki 4-amino-imidazochinolinowe
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201415573D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201415569D0 (en) Therapeutic Compounds
GB201417369D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201406591D0 (en) Compounds
ZA201700555B (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419228D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201417168D0 (en) Compounds
HK1232121A1 (zh) 作為抗氧化治療的富勒烯化合物
GB201416273D0 (en) Therapeutic compounds
GB201419015D0 (en) Compounds
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
GB201409405D0 (en) Therapeutic compounds
GB201407122D0 (en) Therapeutic compounds